New South Wales leukaemia patient Chris Brugger has been able to go back to work part-time in between travelling to Sydney for medical treatment .
The 35-year-old from Griffiths says the new drug Brentuximab Vedotin has improved his condition dramatically .
His family say it reinforces why it is essential to get Hodgkin's Lymphoma treatment on the PBS system .